These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Potency of an inactivated avian influenza vaccine prepared from a non-pathogenic H5N1 reassortant virus generated between isolates from migratory ducks in Asia. Isoda N, Sakoda Y, Kishida N, Soda K, Sakabe S, Sakamoto R, Imamura T, Sakaguchi M, Sasaki T, Kokumai N, Ohgitani T, Saijo K, Sawata A, Hagiwara J, Lin Z, Kida H. Arch Virol; 2008; 153(9):1685-92. PubMed ID: 18651092 [Abstract] [Full Text] [Related]
3. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens. Jadhao SJ, Lee CW, Sylte M, Suarez DL. Vaccine; 2009 Oct 19; 27(44):6247-60. PubMed ID: 19686695 [Abstract] [Full Text] [Related]
4. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions. Veits J, Römer-Oberdörfer A, Helferich D, Durban M, Suezer Y, Sutter G, Mettenleiter TC. Vaccine; 2008 Mar 20; 26(13):1688-96. PubMed ID: 18291561 [Abstract] [Full Text] [Related]
5. Long lasting immunity in chickens induced by a single shot of influenza vaccine prepared from inactivated non-pathogenic H5N1 virus particles against challenge with a highly pathogenic avian influenza virus. Sasaki T, Kokumai N, Ohgitani T, Sakamoto R, Takikawa N, Lin Z, Okamatsu M, Sakoda Y, Kida H. Vaccine; 2009 Aug 20; 27(38):5174-7. PubMed ID: 19596414 [Abstract] [Full Text] [Related]
6. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase. Pavlova SP, Veits J, Keil GM, Mettenleiter TC, Fuchs W. Vaccine; 2009 Jan 29; 27(5):773-85. PubMed ID: 19041677 [Abstract] [Full Text] [Related]
7. Partial heterologous protection by low pathogenic H9N2 virus against natural H9N2-PB1 gene reassortant highly pathogenic H5N1 virus in chickens. Dash SK, Kumar M, Kataria JM, Nagarajan S, Tosh C, Murugkar HV, Kulkarni DD. Microb Pathog; 2016 Jun 29; 95():157-165. PubMed ID: 27057675 [Abstract] [Full Text] [Related]
8. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses. Shi H, Liu XF, Zhang X, Chen S, Sun L, Lu J. Vaccine; 2007 Oct 16; 25(42):7379-84. PubMed ID: 17870216 [Abstract] [Full Text] [Related]
9. The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickens. Webster RG, Webby RJ, Hoffmann E, Rodenberg J, Kumar M, Chu HJ, Seiler P, Krauss S, Songserm T. Virology; 2006 Aug 01; 351(2):303-11. PubMed ID: 16690097 [Abstract] [Full Text] [Related]
10. Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector. Jiang Y, Yu K, Zhang H, Zhang P, Li C, Tian G, Li Y, Wang X, Ge J, Bu Z, Chen H. Antiviral Res; 2007 Sep 01; 75(3):234-41. PubMed ID: 17451817 [Abstract] [Full Text] [Related]
11. Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype. Pavlova SP, Veits J, Mettenleiter TC, Fuchs W. Vaccine; 2009 Aug 13; 27(37):5085-90. PubMed ID: 19573638 [Abstract] [Full Text] [Related]
12. Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics. Tian G, Zhang S, Li Y, Bu Z, Liu P, Zhou J, Li C, Shi J, Yu K, Chen H. Virology; 2005 Oct 10; 341(1):153-62. PubMed ID: 16084554 [Abstract] [Full Text] [Related]
13. Pathogenicity of highly pathogenic avian influenza viruses of H5N1 subtype isolated in Thailand for different poultry species. Saito T, Watanabe C, Takemae N, Chaisingh A, Uchida Y, Buranathai C, Suzuki H, Okamatsu M, Imada T, Parchariyanon S, Traiwanatam N, Yamaguchi S. Vet Microbiol; 2009 Jan 01; 133(1-2):65-74. PubMed ID: 18675524 [Abstract] [Full Text] [Related]
14. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus. Römer-Oberdörfer A, Veits J, Helferich D, Mettenleiter TC. Vaccine; 2008 May 02; 26(19):2307-13. PubMed ID: 18395947 [Abstract] [Full Text] [Related]
18. [The deletion of nucleotides of NS gene from 263 to 277 of H5N1 increases viral virulence in chicken]. Long JX, Xue F, Peng Y, Gu M, Liu XF. Wei Sheng Wu Xue Bao; 2006 Apr 02; 46(2):301-5. PubMed ID: 16736596 [Abstract] [Full Text] [Related]
19. Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate. Grund C, Abdelwhab el-SM, Arafa AS, Ziller M, Hassan MK, Aly MM, Hafez HM, Harder TC, Beer M. Vaccine; 2011 Jul 26; 29(33):5567-73. PubMed ID: 21244859 [Abstract] [Full Text] [Related]
20. An inactivated H5N2 vaccine reduces transmission of highly pathogenic H5N1 avian influenza virus among native chickens. Poetri ON, Bouma A, Murtini S, Claassen I, Koch G, Soejoedono RD, Stegeman JA, van Boven M. Vaccine; 2009 May 11; 27(21):2864-9. PubMed ID: 19428896 [Abstract] [Full Text] [Related] Page: [Next] [New Search]